NCT00758498

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

A 3-Day, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Armodafinil Treatment (50 and 150 mg/Day) in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 427 (actual)
• Sponsor: Cephalon · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group study of armodafinil and placebo treatment in healthy subjects with excessive sleepiness associated with jet lag disorder.

Conditions

• Excessive Sleepiness

Interventions

Type	Name	Description
DRUG	armodafinil	50 mg/day orally, once daily in the morning for 3 days
DRUG	armodafinil	150 mg/day orally, once daily in the morning for 3 days
DRUG	placebo	placebo tablets, once daily in the morning for 3 days

Timeline

• Start date: 2008-09-01
• Primary completion: 2009-02-01
• Completion: 2009-02-01
• First posted: 2008-09-25
• Last updated: 2013-07-19
• Results posted: 2010-07-08

Locations

4 sites across 1 country: United States